Literature DB >> 20082287

Matrix-assisted laser desorption/ionization imaging mass spectrometry of oxaliplatin derivatives in heated intraoperative chemotherapy (HIPEC)-like treated rat kidney.

Amina Bouslimani1, Nicole Bec, Matthias Glueckmann, Christophe Hirtz, Christian Larroque.   

Abstract

Oxaliplatin [1,2-diaminocyclohexane (dach)-Pt complex] is a platinum anticancer drug which is mainly used in the treatment of advanced colorectal cancer, particularly in Heated Intraoperative Chemotherapy (HIPEC) for the treatment of colorectal peritoneal carcinomatosis. In order to better understand the penetration of oxaliplatin in treated tissues we performed a direct imaging of tissue sections from HIPEC-like treated rat kidney using matrix-assisted laser desorption/ionization (MALDI) mass spectrometry. This procedure allowed the detection and localization of oxaliplatin and its metabolites, the monocysteine and monomethionine complexes, in kidney sections. Specifically, oxaliplatin and its metabolites were localized exclusively in the kidney cortex, suggesting that it did not penetrate deeply into the organ. Based on these results, an imaging analysis of human tumors collected after HIPEC is currently in progress to assess the distribution of oxaliplatin and/or metabolites with the aim of defining clinical conditions to improve drug penetration. Copyright (c) 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20082287     DOI: 10.1002/rcm.4408

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  14 in total

Review 1.  Mass spectrometry imaging for drugs and metabolites.

Authors:  Tyler Greer; Robert Sturm; Lingjun Li
Journal:  J Proteomics       Date:  2011-04-13       Impact factor: 4.044

Review 2.  Molecular imaging by mass spectrometry--looking beyond classical histology.

Authors:  Kristina Schwamborn; Richard M Caprioli
Journal:  Nat Rev Cancer       Date:  2010-08-19       Impact factor: 60.716

Review 3.  Mass spectrometric imaging for biomedical tissue analysis.

Authors:  Kamila Chughtai; Ron M A Heeren
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 4.  Molecular mass spectrometry imaging in biomedical and life science research.

Authors:  Jaroslav Pól; Martin Strohalm; Vladimír Havlíček; Michael Volný
Journal:  Histochem Cell Biol       Date:  2010-10-28       Impact factor: 4.304

Review 5.  Imaging of intact tissue sections: moving beyond the microscope.

Authors:  Erin H Seeley; Kristina Schwamborn; Richard M Caprioli
Journal:  J Biol Chem       Date:  2011-06-01       Impact factor: 5.157

Review 6.  MALDI imaging mass spectrometry for direct tissue analysis: technological advancements and recent applications.

Authors:  Benjamin Balluff; Cedrik Schöne; Heinz Höfler; Axel Walch
Journal:  Histochem Cell Biol       Date:  2011-07-30       Impact factor: 4.304

7.  Chemical mapping of the colorectal cancer microenvironment via MALDI imaging mass spectrometry (MALDI-MSI) reveals novel cancer-associated field effects.

Authors:  R Mirnezami; K Spagou; P A Vorkas; M R Lewis; J Kinross; E Want; H Shion; R D Goldin; A Darzi; Z Takats; E Holmes; O Cloarec; J K Nicholson
Journal:  Mol Oncol       Date:  2013-09-14       Impact factor: 6.603

Review 8.  MALDI imaging mass spectrometry--painting molecular pictures.

Authors:  Kristina Schwamborn; Richard M Caprioli
Journal:  Mol Oncol       Date:  2010-09-25       Impact factor: 6.603

Review 9.  Mass spectrometry imaging of therapeutics from animal models to three-dimensional cell cultures.

Authors:  Xin Liu; Amanda B Hummon
Journal:  Anal Chem       Date:  2015-07-02       Impact factor: 6.986

Review 10.  Future technology insight: mass spectrometry imaging as a tool in drug research and development.

Authors:  D F Cobice; R J A Goodwin; P E Andren; A Nilsson; C L Mackay; R Andrew
Journal:  Br J Pharmacol       Date:  2015-05-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.